BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 30357906)

  • 1. Evaluation of U. S. National Toxicology Program (NTP) mouse lymphoma assay data using International Workshop on Genotoxicity Tests (IWGT) and the Organization for Economic Co-Operation and Development (OECD) criteria.
    Schisler MR; Gollapudi BB; Moore MM
    Environ Mol Mutagen; 2018 Dec; 59(9):829-841. PubMed ID: 30357906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Mouse Lymphoma Cell (L5178Y Tk
    Schisler MR; Moore MM; Gollapudi BB
    Methods Mol Biol; 2019; 2031():3-28. PubMed ID: 31473952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse lymphoma thymidine kinase gene mutation assay: follow-up meeting of the International Workshop on Genotoxicity Testing--Aberdeen, Scotland, 2003--Assay acceptance criteria, positive controls, and data evaluation.
    Moore MM; Honma M; Clements J; Bolcsfoldi G; Burlinson B; Cifone M; Clarke J; Delongchamp R; Durward R; Fellows M; Gollapudi B; Hou S; Jenkinson P; Lloyd M; Majeska J; Myhr B; O'Donovan M; Omori T; Riach C; San R; Stankowski LF; Thakur AK; Van Goethem F; Wakuri S; Yoshimura I
    Environ Mol Mutagen; 2006 Jan; 47(1):1-5. PubMed ID: 15991242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the mouse lymphoma forward mutational assay: the Gene-Tox program database.
    Grant SG; Zhang YP; Klopman G; Rosenkranz HS
    Mutat Res; 2000 Feb; 465(1-2):201-29. PubMed ID: 10708987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse lymphoma thymidine kinase gene mutation assay: meeting of the International Workshop on Genotoxicity Testing, San Francisco, 2005, recommendations for 24-h treatment.
    Moore MM; Honma M; Clements J; Bolcsfoldi G; Burlinson B; Cifone M; Clarke J; Clay P; Doppalapudi R; Fellows M; Gollapudi B; Hou S; Jenkinson P; Muster W; Pant K; Kidd DA; Lorge E; Lloyd M; Myhr B; O'Donovan M; Riach C; Stankowski LF; Thakur AK; Van Goethem F;
    Mutat Res; 2007 Feb; 627(1):36-40. PubMed ID: 17157054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spectral karyotype of L5178Y TK⁺/⁻ mouse lymphoma cells clone 3.7.2C and factors affecting mutant frequency at the thymidine kinase (tk) locus in the microtitre mouse lymphoma assay.
    Fellows MD; McDermott A; Clare KR; Doherty A; Aardema MJ
    Environ Mol Mutagen; 2014 Jan; 55(1):35-42. PubMed ID: 24375635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro mouse lymphoma (L5178Y Tk⁺/⁻-3.7.2C) forward mutation assay.
    Schisler MR; Moore MM; Gollapudi BB
    Methods Mol Biol; 2013; 1044():27-50. PubMed ID: 23896870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A method to distinguish between the de novo induction of thymidine kinase mutants and the selection of pre-existing thymidine kinase mutants in the mouse lymphoma assay.
    Wang J; Heflich RH; Moore MM
    Mutat Res; 2007 Jan; 626(1-2):185-90. PubMed ID: 17055776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical review of styrene genotoxicity focused on the mutagenicity/clastogenicity literature and using current organization of economic cooperation and development guidance.
    Moore MM; Pottenger LH; House-Knight T
    Environ Mol Mutagen; 2019 Aug; 60(7):624-663. PubMed ID: 30786062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The L5178Y/tk+/- mouse lymphoma specific gene and chromosomal mutation assay a phase III report of the U.S. Environmental Protection Agency Gene-Tox Program.
    Mitchell AD; Auletta AE; Clive D; Kirby PE; Moore MM; Myhr BC
    Mutat Res; 1997 Nov; 394(1-3):177-303. PubMed ID: 9434856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse lymphoma thymidine kinase gene mutation assay: International Workshop on Genotoxicity Tests Workgroup report--Plymouth, UK 2002.
    Moore MM; Honma M; Clements J; Bolcsfoldi G; Cifone M; Delongchamp R; Fellows M; Gollapudi B; Jenkinson P; Kirby P; Kirchner S; Muster W; Myhr B; O'Donovan M; Oliver J; Omori T; Ouldelhkim MC; Pant K; Preston R; Riach C; San R; Stankowski LF; Thakur A; Wakuri S; Yoshimura I;
    Mutat Res; 2003 Oct; 540(2):127-40. PubMed ID: 14550497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suitable top concentration for tests with mammalian cells: mouse lymphoma assay workgroup.
    Moore MM; Honma M; Clements J; Awogi T; Douglas GR; van Goethem F; Gollapudi B; Kimura A; Muster W; O'Donovan M; Schoeny R; Wakuri S
    Mutat Res; 2011 Aug; 723(2):84-6. PubMed ID: 21514400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian cell HPRT gene mutation assay: test methods.
    Johnson GE
    Methods Mol Biol; 2012; 817():55-67. PubMed ID: 22147568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisiting the bacterial mutagenicity assays: Report by a workgroup of the International Workshops on Genotoxicity Testing (IWGT).
    Schoeny R; Cross KP; DeMarini DM; Elespuru R; Hakura A; Levy DD; Williams RV; Zeiger E; Escobar PA; Howe JR; Kato M; Lott J; Moore MM; Simon S; Stankowski LF; Sugiyama KI; van der Leede BM
    Mutat Res Genet Toxicol Environ Mutagen; 2020 Jan; 849():503137. PubMed ID: 32087853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the mouse lymphoma tk assay (microwell method) as an alternative to the in vitro chromosomal aberration test.
    Honma M; Hayashi M; Shimada H; Tanaka N; Wakuri S; Awogi T; Yamamoto KI; Kodani N; Nishi Y; Nakadate M; Sofuni T
    Mutagenesis; 1999 Jan; 14(1):5-22. PubMed ID: 10474816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of published data for top concentration considerations in mammalian cell genotoxicity testing.
    Parry JM; Parry E; Phrakonkham P; Corvi R
    Mutagenesis; 2010 Nov; 25(6):531-8. PubMed ID: 20720196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.